This is a current listing of active clinical trials at the Aspirus Regional Cancer Center. From this list you can select a specific cancer that you are interested in (for example, breast or colon cancer) and then review the clinical trials that are active at the Aspirus Regional Cancer Center for that specific disease.
Advanced Non-Squamous NSCLC
Trial Name: A Phase II Study of L-BLP25 and Bevacizumab in Unresectable Stage IIIA and IIIB Non-Squamous Non-Small Cell Lung Cancer after Definitive Chemoradiation
Protocol ID: E6508
Patients must have newly diagnosed histologically confirmed non-squamous non-small cell lung cancer (adeno, large cell undifferentiated, bronchoalveolar, and non-small cell carcinoma NOS).
Patients must not have CNS metastases.
Patients must have no other active malignancies
Patients must be 18 years of age an older
Must meet required laboratory values
Patients must not have had prior chest radiation.
Patients must not have any autoimmune disease.
Patients must not have known Hepatitis B or C.
Women must not be pregnant or breast-feeding due to potential harm to the fetus or infant from cytotoxic chemotherapy and the unknown risk from bevacizumab
Women of childbearing potential and sexually active males must agree to use accepted and effective method of contraception prior to study entry, during study treatment and for at least 6 months after completion of bevacizumab.
No prior splenectomy allowed.
Patients must not have any known hypersensitivity to any component of bevacizumab.
Enrollment: 1282 people will take part in this study at several medical centers.
Taking part in this study may or may not make your health better.While doctors hope that the medications will be more useful against cancer compared to the usual treatment, there is no proof of this yet.We do know that the information from this study will help doctors learn more about maintenance therapy as a treatment for cancer.This information could help future cancer patients.
These clinical trial overviews are intended to provide a brief overview of the clinical trial. To help determine whether the trial is appropriate for you, the major eligibility criteria are listed above. To obtain more information on the eligibility and the treatment plan, please contact our Oncology Clinical Research Coordinator, Beth Knetter at 715-847-2353 or 1-800-283-2881, ext.72353.